Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2876939 | The Annals of Thoracic Surgery | 2011 | 6 Pages |
Abstract
Of patients who survive LC or HNC, the latter are much more likely to develop a new pulmonary malignancy. Lung cancers that develop after HNC have a poor prognosis. This phenomenon is not explained by misclassified metastases, because histologically discordant cases behave just as poorly. Enhanced surveillance and chemoprevention strategies are needed to detect and prevent subsequent primary LC in survivors of HNC.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Vijayvel MBBS, PhD, Cheng BS, Mary PhD, Elisabeth U. MD, Chukwumere E. MD, Wesley MD, Maureen DDS, Todd L. MD, Sai MBBS,